PRCT
Procept Biorobotics Corp
17.20$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.0% | -56.9% | -72.5% | -29.5% | -32.2% | -47.5% | -24.6% | -19.0% | -8.0% | -13.5% | -45.9% | -60.7% | -33.3% | |
| 3.0% | 3.0% | 2.7% | 2.4% | 2.3% | 2.1% | 2.1% | 2.0% | 1.9% | 2.2% | 2.1% | 3.9% | 2.6% | |
| 15.2% | 11.4% | 14.0% | 15.0% | 14.6% | 13.3% | 14.6% | 15.4% | 17.4% | 14.2% | 15.7% | 29.2% | 19.6% | |
| -3.2% | -8.0% | -30.8% | -0.4% | -14.5% | -36.6% | -6.3% | -12.0% | -2.4% | 10.5% | -26.3% | -33.5% | -14.1% | |
| 16.5% | 20.0% | 4.4% | 2.0% | 0.4% | 1.7% | 2.7% | 3.5% | 3.4% | 2.4% | 3.5% | 6.2% | 4.0% | |
| -16.5% | -20.0% | -4.4% | -2.0% | -0.4% | -1.7% | -2.7% | -3.5% | -3.4% | -2.4% | -3.5% | -6.2% | -4.0% | |
| – | 8.3% | – | – | 3.6% | – | – | – | 4.2% | -0.8% | – | – | – | |
| 461.9% | 6.6% | 5.8% | 9.9% | 2.9% | 249.9% | 1.9% | 5.5% | 1.3% | 5.8% | 0.3% | 5.0% | 3.1% | |
| 391.4% | -70.3% | -71.1% | -21.5% | -29.7% | 200.7% | -25.3% | -17.0% | -10.1% | -10.2% | -49.2% | -62.0% | -34.3% | |
| -70.4% | -76.9% | -76.9% | -31.4% | -32.6% | -49.2% | -27.2% | -22.5% | -11.4% | -15.9% | -49.4% | -66.9% | -37.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.